{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T16:22:10Z","timestamp":1792858930354,"version":"4.5.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.reprotox.2009.02.014","type":"journal-article","created":{"date-parts":[[2009,3,14]],"date-time":"2009-03-14T06:37:46Z","timestamp":1237012666000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":451,"title":["Valproic acid in pregnancy: How much are we endangering the embryo and fetus?"],"prefix":"10.1016","volume":"28","author":[{"given":"Asher","family":"Ornoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.reprotox.2009.02.014_bib1","first-page":"382","article-title":"Clinical teratology, an expanding area in preventive antenatal care","volume":"159","author":"Ornoy","year":"1993","journal-title":"Western J Med"},{"key":"10.1016\/j.reprotox.2009.02.014_bib2","first-page":"205","article-title":"The effects of psychotropic drugs in pregnancy and lactation. Invited review","volume":"37","author":"Arnon","year":"2000","journal-title":"Isr J Psych"},{"key":"10.1016\/j.reprotox.2009.02.014_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0378-4274(02)00505-2","article-title":"The impact of intrauterine exposure versus postnatal environment in neurodevelopment toxicity: long term neurobehavioral studies in children at risk for developmental disorders","volume":"140\/141","author":"Ornoy","year":"2003","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.reprotox.2009.02.014_bib4","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.reprotox.2006.03.014","article-title":"Neuroteratogens in man: an overview with special emphasis on antiepileptic drugs in pregnancy","volume":"22","author":"Ornoy","year":"2006","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.reprotox.2009.02.014_bib5","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1289\/txg.7034","article-title":"Valproic acid teratogenicity: a toxicogenomic approach","volume":"112","author":"Kultima","year":"2004","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.reprotox.2009.02.014_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0920-1211(98)00084-9","article-title":"Congenital malformations due to antiepileptic drugs","volume":"33","author":"Kaneko","year":"1999","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.reprotox.2009.02.014_bib7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/00023210-200822040-00004","article-title":"Pregnancy outcome after in utero exposure to valproate: a dose relationship in teratogenic effect","volume":"22","author":"Diav-Citrin","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.reprotox.2009.02.014_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","article-title":"Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK epilepsy and pregnancy register","volume":"77","author":"Morrow","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl. 5","key":"10.1016\/j.reprotox.2009.02.014_bib9","first-page":"75","article-title":"Epilepsy, antiepileptic drugs, and malformations in children of women with epilepsy: a French prospective cohort study","volume":"42","author":"Dravet","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.reprotox.2009.02.014_bib10","doi-asserted-by":"crossref","first-page":"F90","DOI":"10.1136\/adc.2004.067421","article-title":"Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndrome","volume":"91","author":"Kini","year":"2006","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.reprotox.2009.02.014_bib11","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(72)92209-X","article-title":"Maternal epilepsy and abnormalities of the fetus and newborn","volume":"2","author":"Speidel","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.reprotox.2009.02.014_bib12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/00016347309158321","article-title":"The course and outcome of pregnancy in women with epilepsy","volume":"52","author":"Bjerkedal","year":"1973","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.reprotox.2009.02.014_bib13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0140-6736(76)91403-3","article-title":"Anticonvulsants and parental epilepsy in the development of birth defects","volume":"1","author":"Shapiro","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.reprotox.2009.02.014_bib14","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1212\/01.WNL.0000044157.28073.DC","article-title":"Major malformations in offspring of women with epilepsy","volume":"60","author":"Kaaja","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.reprotox.2009.02.014_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2165\/00002018-200427030-00004","article-title":"Malformation rates in children of women with untreated epilepsy","volume":"27","author":"Fried","year":"2004","journal-title":"Drug Saf"},{"key":"10.1016\/j.reprotox.2009.02.014_bib16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0022-3476(80)80517-8","article-title":"Teratogenicity of valproic acid","volume":"97","author":"Dalens","year":"1980","journal-title":"J Pediatr"},{"key":"10.1016\/j.reprotox.2009.02.014_bib17","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0022-3476(81)80743-3","article-title":"Possible teratogenicity of valproic acid","volume":"98","author":"Gomez","year":"1981","journal-title":"J Pediatr"},{"key":"10.1016\/j.reprotox.2009.02.014_bib18","first-page":"1096","article-title":"Valproic acid and spina bifida","volume":"2","author":"Robert","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.reprotox.2009.02.014_bib19","first-page":"445","article-title":"Is valproic acid teratogenic?","volume":"139","author":"Robert","year":"1983","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.reprotox.2009.02.014_bib20","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(82)90018-6","article-title":"Valproic acid and spina bifida","volume":"2","author":"Bjerkedal","year":"1982","journal-title":"Lancet"},{"issue":"Suppl. 5","key":"10.1016\/j.reprotox.2009.02.014_bib21","first-page":"111","article-title":"Spectrum of neural-tube defects in 34 infants prenatally exposed to antiepileptic drugs","volume":"42","author":"Lindhout","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.reprotox.2009.02.014_bib22","first-page":"119","article-title":"The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort","volume":"42","author":"Omtzigt","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.reprotox.2009.02.014_bib23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ajmg.1320190308","article-title":"The fetal valproate syndrome","volume":"19","author":"DiLiberti","year":"1984","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.reprotox.2009.02.014_bib24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ajmg.1320290123","article-title":"Verification of the fetal valproate syndrome phenotype","volume":"29","author":"Ardinger","year":"1988","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.reprotox.2009.02.014_bib25","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1212\/01.WNL.0000163771.96962.1F","article-title":"Antiepileptic drug use of women with epilepsy and congenital malformations in offspring","volume":"64","author":"Artama","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.reprotox.2009.02.014_bib26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1651-2227.2004.tb00701.x","article-title":"Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study","volume":"93","author":"Wide","year":"2004","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.reprotox.2009.02.014_bib27","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/01.WNL.0000154516.43630.C5","article-title":"Antiepileptic drug pregnancy registry. Increased rate of major malformations in offspring exposed to valproate during pregnancy","volume":"64","author":"Wyszynski","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.reprotox.2009.02.014_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/tcrm.1.1.21.53605","article-title":"Should valproate be taken during pregnancy?","volume":"1","author":"Eadie","year":"2005","journal-title":"Therap Clin Risk Manag"},{"key":"10.1016\/j.reprotox.2009.02.014_bib29","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1479-828X.2007.00781.x","article-title":"The Australian register of antiepileptic drugs in pregnancy: the first 1002 pregnancies","volume":"47","author":"Vajda","year":"2007","journal-title":"Aust NZ J Obstetr Gynecol"},{"key":"10.1016\/j.reprotox.2009.02.014_bib30","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1528-1157.1997.tb01480.x","article-title":"Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy","volume":"38","author":"Samren","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.reprotox.2009.02.014_bib31","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1517\/14740338.4.2.345","article-title":"Teratogenicity of sodium valporate","volume":"4","author":"Alsdorf","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.reprotox.2009.02.014_bib32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1212\/01.wnl.0000227919.81208.b2","article-title":"In utero antiepileptic drug exposure: fetal death and malformations","volume":"67","author":"Meador","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.reprotox.2009.02.014_bib33","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1528-1167.2008.01696.x","article-title":"Valproate teratogenicity and epilepsy syndrome","volume":"49","author":"Bromfield","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.reprotox.2009.02.014_bib34","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S1059-1311(02)00135-8","article-title":"Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate","volume":"11","author":"Mawer","year":"2002","journal-title":"Seizures"},{"key":"10.1016\/j.reprotox.2009.02.014_bib35","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1528-1157.1999.tb00851.x","article-title":"Malformations of offspring of women with epilepsy: a prospective study","volume":"40","author":"Canger","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.reprotox.2009.02.014_bib36","first-page":"441","article-title":"Major malformations with valproic acid","volume":"52","author":"Koren","year":"2006","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.reprotox.2009.02.014_bib37","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1474-4422(05)70224-6","article-title":"Birth defects after prenatal exposure to antiepileptic drugs","volume":"4","author":"Perucca","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.reprotox.2009.02.014_bib38","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/jmg.37.7.489","article-title":"A clinical study of 57 children with fetal anticonvulsant syndromes","volume":"37","author":"Moore","year":"2000","journal-title":"J Med Genet"},{"key":"10.1016\/j.reprotox.2009.02.014_bib39","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1212\/WNL.59.4.630","article-title":"Valproate embryopathy in three sets of siblings: further proof of hereditary susceptibility","volume":"59","author":"Malm","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.reprotox.2009.02.014_bib40","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0733-8619(18)30075-6","article-title":"Pregnancy, teratogenesis and epilepsy","volume":"12","author":"Yerby","year":"1994","journal-title":"Neurol Clin"},{"key":"10.1016\/j.reprotox.2009.02.014_bib41","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1517\/14740338.4.2.345","article-title":"Teratogenicity of sodium valproate","volume":"4","author":"Alsdorf","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.reprotox.2009.02.014_bib42","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2165\/00002018-200831060-00008","article-title":"Risk of hypospadias in newborn infants exposed to valproic acid during the first trimester of pregnancy: a case\u2013control study in Spain","volume":"31","author":"Rodr\u00edguez-Pinilla","year":"2008","journal-title":"Drug Saf"},{"key":"10.1016\/j.reprotox.2009.02.014_bib43","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1212\/WNL.61.6_suppl_2.S23","article-title":"Management issues for women with epilepsy. Neural tube defects and folic acid supplementation","volume":"61","author":"Yerby","year":"2003","journal-title":"Neurology"},{"issue":"Suppl. 4","key":"10.1016\/j.reprotox.2009.02.014_bib44","first-page":"S19","article-title":"Teratogenic effects of antiepileptic drugs: implications for the management of epilepsy in women of childbearing age","volume":"35","author":"Lindhout","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.reprotox.2009.02.014_bib45","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-008-0029-1","article-title":"Spontaneous abortions and the prophylactic affect of folic acid supplementation in epileptic women undergoing antiepileptic therapy","author":"Pittschieler","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.reprotox.2009.02.014_bib46","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/seiz.1999.0283","article-title":"Failure of periconceptual folic acid to prevent a neural tube defect in the offspring of a mother taking sodium valproate","volume":"8","author":"Craig","year":"1999","journal-title":"Seizure"},{"key":"10.1016\/j.reprotox.2009.02.014_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002018-200629010-00001","article-title":"Valproic acid in epilepsy: pregnancy related issues","volume":"29","author":"Genton","year":"2006","journal-title":"Drug Saf"},{"key":"10.1016\/j.reprotox.2009.02.014_bib48","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000263924","article-title":"Isolated fetal bilateral radial ray reduction associated with valproic acid usage","volume":"9","author":"Langer","year":"1994","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.reprotox.2009.02.014_bib49","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1442-200X.1995.tb03686.x","article-title":"Fetal valproate syndrome with reduction deformity of limb","volume":"37","author":"Okada","year":"1995","journal-title":"Acta Paediatr Jpn"},{"key":"10.1016\/j.reprotox.2009.02.014_bib50","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/BF02106290","article-title":"Proximal phocomelia and radial ray aplasia in fetal valproic acid syndrome","volume":"149","author":"Verloes","year":"1990","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.reprotox.2009.02.014_bib51","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/(SICI)1096-8628(20000228)90:5<376::AID-AJMG6>3.0.CO;2-V","article-title":"Prenatal exposure to valproic acid during pregnancy and limb deficiencies: a case\u2013control study","volume":"90","author":"Rodr\u00edguez-Pinilla","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.reprotox.2009.02.014_bib52","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF01954275","article-title":"Omphalocele in a newborn baby exposed to sodium valproate in utero","volume":"154","author":"Boussemart","year":"1995","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.reprotox.2009.02.014_bib53","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1699-0463.1998.tb01350.x","article-title":"Lung hypoplasia\u2014a possible teratogenic effect of valproate. Case report","volume":"106","author":"Janas","year":"1998","journal-title":"APMIS"},{"key":"10.1016\/j.reprotox.2009.02.014_bib54","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1136\/jmg.24.11.692","article-title":"Fetal valproate syndrome: is there a recognizable phenotype?","volume":"24","author":"Winter","year":"1987","journal-title":"J Med Genet"},{"key":"10.1016\/j.reprotox.2009.02.014_bib55","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/1096-8628(20010115)98:2<168::AID-AJMG1026>3.0.CO;2-O","article-title":"Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature","volume":"98","author":"Kozma","year":"2001","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.reprotox.2009.02.014_bib56","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/seiz.2000.0392","article-title":"Developing diagnostic criteria for the fetal anticonvulsant syndrome","volume":"9","author":"Dean","year":"2000","journal-title":"Seizures"},{"key":"10.1016\/j.reprotox.2009.02.014_bib57","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(06)68627-3","article-title":"Prenatal exposure to antiepileptic drugs","volume":"367","author":"Perucca","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.reprotox.2009.02.014_bib58","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/jmg.39.4.251","article-title":"Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth","volume":"39","author":"Dean","year":"2002","journal-title":"J Med Genet"},{"key":"10.1016\/j.reprotox.2009.02.014_bib59","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1212\/WNL.62.1.28","article-title":"Normal intelligence in children with prenatal exposure to carbamazepine","volume":"62","author":"Gaily","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.reprotox.2009.02.014_bib60","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1651-2227.1996.tb14137.x","article-title":"Antiepileptic drug treatment in pregnancy: drug side effects in the neonate and neurological outcome","volume":"85","author":"Koch","year":"1996","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.reprotox.2009.02.014_bib61","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.yebeh.2006.08.007","article-title":"The effects of valproate exposure in utero on behavior and the need for educational support in school-aged children","volume":"9","author":"Viinikainen","year":"2006","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.reprotox.2009.02.014_bib62","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/jnnp.70.1.15","article-title":"Additional educational needs in children born to mothers with epilepsy","volume":"70","author":"Adab","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.reprotox.2009.02.014_bib63","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1136\/jnnp.2003.029132","article-title":"The longer term outcome of children born to mothers with epilepsy","volume":"75","author":"Adab","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.reprotox.2009.02.014_bib64","unstructured":"Meador KJ. In utero antiepileptic drugs: differential cognitive outcomes in children of women with epilepsy. Presented at American Epilepsy Society 12; 2006."},{"key":"10.1016\/j.reprotox.2009.02.014_bib65","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.eplepsyres.2005.06.001","article-title":"Children exposed to valproate in utero\u2014population based evaluation of risks and confounding factors for long-term neurocognitive development","volume":"65","author":"Eriksson","year":"2005","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.reprotox.2009.02.014_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2008.03.004","article-title":"Neurodevelopmental delay in children exposed to antiepileptic drugs in utero: a critical review directed at structural study-bias","volume":"271","author":"Nicolai","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.reprotox.2009.02.014_bib67","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1469-8749.1994.tb11858.x","article-title":"Fetal valproate syndrome: clinical and neurodevelopmental features in two sibling pairs","volume":"36","author":"Christianson","year":"1994","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.reprotox.2009.02.014_bib68","first-page":"39632","article-title":"A male with fetal valproate syndrome and autism","author":"Williams","year":"1997","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.reprotox.2009.02.014_bib69","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1469-8749.2001.tb00188.x","article-title":"Fetal valproate syndrome and autism: additional evidence of an association","volume":"43","author":"Williams","year":"2001","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.reprotox.2009.02.014_bib70","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0012162205001076","article-title":"Characteristics of fetal anticonvulsant syndrome associated with autistic disorder","volume":"47","author":"Rasalam","year":"2005","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.reprotox.2009.02.014_bib71","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s10803-006-0117-y","article-title":"A new neurobehavioral model of autism in mice: pre and postnatal exposure to sodium valproate","volume":"36","author":"Wagner","year":"2006","journal-title":"Autism Dev Disord"},{"key":"10.1016\/j.reprotox.2009.02.014_bib72","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijdevneu.2004.11.001","article-title":"The teratology of autism","volume":"23","author":"Arndt","year":"2005","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.reprotox.2009.02.014_bib73","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0890-6238(91)90017-A","article-title":"Diurnal variation of folate concentrations in mouse embryo and plasma: the protective effect of folinic acid on valproic acid induced teratogenicity is time dependent","volume":"5","author":"Wegner","year":"1991","journal-title":"Reprod Toxicol"},{"issue":"Suppl. 5","key":"10.1016\/j.reprotox.2009.02.014_bib74","first-page":"17","article-title":"Alteration of embryonic folate metabolism by valproic acid during organogenesis: implication for mechanism of teratogenesis","volume":"42","author":"Wegner","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.reprotox.2009.02.014_bib75","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.taap.2005.07.008","article-title":"Folic acid and pantothenic acid protection against valproic acid-induced neural tube defect in CD 1 mice","volume":"211","author":"Dawson","year":"2006","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.reprotox.2009.02.014_bib76","series-title":"Epilepsy, pregnancy, and the child","first-page":"367","article-title":"Placental transfer and neonatal pharmacokinetics of valproic acid and some of its metabolites","author":"Nau","year":"1982"},{"key":"10.1016\/j.reprotox.2009.02.014_bib77","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1365-2125.1984.tb02414.x","article-title":"Differential transplacental binding of valproic acid: influence of free fatty acids","volume":"17","author":"Albani","year":"1984","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.reprotox.2009.02.014_bib78","series-title":"Drugs and human lactation","first-page":"341","year":"1988"},{"key":"10.1016\/j.reprotox.2009.02.014_bib79","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/00007691-198409000-00003","article-title":"Valproic acid in breast milk: how much is really there?","volume":"6","author":"von Unruh","year":"1984","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.reprotox.2009.02.014_bib80","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1528-1157.1978.tb05034.x","article-title":"Excretion of valproic acid into semen of rabbits and man","volume":"19","author":"Swanson","year":"1978","journal-title":"Epilepsia"},{"key":"10.1016\/j.reprotox.2009.02.014_bib81","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1528-1157.1999.tb00752.x","article-title":"Male infertility: possible association with valproate exposure","volume":"40","author":"Yerby","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.reprotox.2009.02.014_bib82","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0890-6238(01)00199-X","article-title":"The teratogenic effects of carbamazepine: a meta-analysis of 1255 exposures","volume":"16","author":"Matalon","year":"2002","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.reprotox.2009.02.014_bib83","unstructured":"GSK The Lamotrigine Pregnancy Registry: http:\/\/pregnancyregistry.gsk.com\/documents\/lam report: January 2008."},{"key":"10.1016\/j.reprotox.2009.02.014_bib84","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0890-6238(98)00035-5","article-title":"Is benzodiazepine use during pregnancy really teratogenic","volume":"12","author":"Ornoy","year":"1998","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.reprotox.2009.02.014_bib85","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1055\/s-2008-1071520","article-title":"Benzodiazepine amplification of valproate teratogenic effects in children of mothers with absence epilepsy","volume":"24","author":"Laegreid","year":"1993","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.reprotox.2009.02.014_bib86","first-page":"367","article-title":"Are antiepileptic drugs harmful when taken during pregnancy?","volume":"22","author":"Janz","year":"1994","journal-title":"Perinat Med"},{"key":"10.1016\/j.reprotox.2009.02.014_bib87","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/(SICI)1096-9926(200003)61:3<196::AID-TERA7>3.0.CO;2-T","article-title":"Intelligence and physical features of children of women with epilepsy","volume":"61","author":"Holmes","year":"2000","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2009.02.014_bib88","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jpeds.2004.08.048","article-title":"The correlation of deficits in IQ with midface and digit hypoplasia in children exposed in utero to anticonvulsant drugs","volume":"146","author":"Holmes","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.reprotox.2009.02.014_bib89","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0272-0590(88)90112-1","article-title":"Evaluation of valproic acid (VPA) developmental toxicity and pharmacokinetics in Sprague-Dawley rats","volume":"11","author":"Binkerd","year":"1988","journal-title":"Fundam Appl Toxicol"},{"key":"10.1016\/j.reprotox.2009.02.014_bib90","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/faat.1994.1029","article-title":"Developmental toxicity and structure\u2013activity relationships of aliphatic acids, including dose\u2013response assessment of valproic acid in mice and rats","volume":"22","author":"Narotsky","year":"1994","journal-title":"Fundam Appl Toxicol"},{"key":"10.1016\/j.reprotox.2009.02.014_bib91","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/tera.1420380405","article-title":"Valproic acid developmental toxicity and pharmacokinetics in the rhesus monkey: an interspecies comparison","volume":"38","author":"Hendrickx","year":"1988","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2009.02.014_bib92","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/tera.1420450208","article-title":"Valproic acid induced spina bifida: a mouse model","volume":"45","author":"Ehlers","year":"1992","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2009.02.014_bib93","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/jn\/126.1.67","article-title":"Methionine reduces the valproic acid-induced spina bifida in mice without altering valproic acid kinetics","volume":"126","author":"Ehlers","year":"1996","journal-title":"J Nutr"},{"key":"10.1016\/j.reprotox.2009.02.014_bib94","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0304-3940(00)01457-9","article-title":"Vitamin E decreases valproic acid neural tube defects in mice","volume":"292","author":"Al Deeb","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.reprotox.2009.02.014_bib95","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0272-0590(92)90137-7","article-title":"Effects of supplementation with folinic acid, vitamin B6 and vitamin B12 on valproic acid-induced teratogenesis in mice","volume":"18","author":"Elmazar","year":"1992","journal-title":"Fundam Appl Toxicol"},{"key":"10.1016\/j.reprotox.2009.02.014_bib96","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1286-0115(04)97999-4","article-title":"Effects of valproic acid on fetal and maternal organs in the mouse: a morphological study","volume":"88","author":"Emmanouil-Nikoloussi","year":"2004","journal-title":"Morphologie"},{"key":"10.1016\/j.reprotox.2009.02.014_bib97","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/(SICI)1096-9861(19960624)370:2<247::AID-CNE8>3.0.CO;2-2","article-title":"Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei","volume":"370","author":"Rodier","year":"1996","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.reprotox.2009.02.014_bib98","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0892-0362(99)00083-5","article-title":"Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism","volume":"22","author":"Ingram","year":"2000","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.reprotox.2009.02.014_bib99","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.npp.1300518","article-title":"Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism","volume":"30","author":"Schneider","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.reprotox.2009.02.014_bib100","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejmg.2007.08.002","article-title":"Influence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero","volume":"50","author":"Kini","year":"2007","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.reprotox.2009.02.014_bib101","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0733-8619(18)30074-4","article-title":"Biochemical and molecular teratology of fetal hydantoin syndrome","volume":"12","author":"Buehler","year":"1994","journal-title":"Neurol Clin"},{"key":"10.1016\/j.reprotox.2009.02.014_bib102","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2165\/00003088-200746040-00001","article-title":"The role of pharmacogenetics in the metabolism of antiepileptic drugs: pharmacokinetic and therapeutic implications","volume":"46","author":"Klotz","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.reprotox.2009.02.014_bib103","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.reprotox.2007.04.004","article-title":"Embryonic oxidative stress as a mechanism of teratogenesis with special emphasis on diabetic embryopathy","volume":"24","author":"Ornoy","year":"2007","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.reprotox.2009.02.014_bib104","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.reprotox.2007.04.005","article-title":"Embryonic cardiac arrhythmia and generation of reactive oxygen species: common teratogenic mechanism for IKr blocking drugs","volume":"24","author":"Danielsson","year":"2007","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.reprotox.2009.02.014_bib105","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.eplepsyres.2007.11.005","article-title":"Increased oxidative stress in epileptic children treated with valproic acid","volume":"78","author":"Verrotti","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.reprotox.2009.02.014_bib106","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.reprotox.2009.02.014_bib107","doi-asserted-by":"crossref","first-page":"27586","DOI":"10.1074\/jbc.M303740200","article-title":"Valproate induces replication-independent active DNA demethylation","volume":"278","author":"Detich","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.reprotox.2009.02.014_bib108","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/10408440591007403","article-title":"Mode of action: inhibition of histone deacetylase, altering WNT-dependent gene expression and regulation of beta catenin\u2014developmental effects of valproic acid","volume":"35","author":"Wiltse","year":"2005","journal-title":"Crit Rev Toxicol"},{"key":"10.1016\/j.reprotox.2009.02.014_bib109","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1096\/fj.04-3425fje","article-title":"Association of valproate-induced teratogenesis with histone deacetylase inhibition in vivo","volume":"19","author":"Gurvich","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.reprotox.2009.02.014_bib110","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ntt.2006.08.004","article-title":"Induction of the homeotic gene Hoxa 1 through valproic acid's teratogenic mechanism of action","volume":"28","author":"Stodgell","year":"2006","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.reprotox.2009.02.014_bib111","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/bdrc.20082","article-title":"Inhibition of histone deacetylase as a new mechanism of teratogenesis","volume":"78","author":"Menegola","year":"2006","journal-title":"Birth Defects Res Part C"},{"key":"10.1016\/j.reprotox.2009.02.014_bib112","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuroscience.2007.06.053","article-title":"Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity","volume":"149","author":"Chen","year":"2007","journal-title":"Neuroscience"}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623809000422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623809000422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:27:38Z","timestamp":1760189258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623809000422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":112,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0890623809000422"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2009.02.014","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproic acid in pregnancy: How much are we endangering the embryo and fetus?","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2009.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}